Search

Author/Creator Nakai, Kenya

2. Concentration–Response Modeling of ECG Data From Early‐Phase Clinical Studies as an Alternative Clinical and Regulatory Approach to Assessing QT Risk — Experience From the Development Program of Lemborexant. (4th August 2016)

Authors:
Murphy, Patricia J.; Yasuda, Sanae; Nakai, Kenya; Yoshinaga, Takashi; Hall, Nancy; Zhou, Meijian; Aluri, Jagadeesh; Rege, Bhaskar; Moline, Margaret; Ferry, Jim; Darpo, Borje
Journal:
Journal of clinical pharmacology
Issue:
Volume 57:Number 1(2017)
Page Start:
96
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Evaluation of the CYP3A and CYP2B6 Drug‐Drug Interaction Potential of Lemborexant. Issue 6 (17th January 2021)

Authors:
Landry, Ishani; Aluri, Jagadeesh; Nakai, Kenya; Hall, Nancy; Miyajima, Yukiko; Ueno, Takashi; Dayal, Satish; Filippov, Gleb; Lalovic, Bojan; Moline, Margaret; Reyderman, Larisa
Journal:
Clinical pharmacology in drug development
Issue:
Volume 10:Issue 6(2021)
Page Start:
681
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. First‐in‐Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742, a Dual Antagonist of Toll‐like Receptors 7 and 8, in Healthy Volunteers. Issue 4 (11th October 2022)

Authors:
Yamakawa, Naoto; Tago, Fumitoshi; Nakai, Kenya; Kitahara, Yasumi; Ikari, Shingo; Hojo, Seiichiro; Hall, Nancy; Aluri, Jagadeesh; Hussein, Ziad; Gevorkyan, Hakop; Maruyama, Tatsuya; Ishizaka, Sally; Yagi, Takuya
Journal:
Clinical pharmacology in drug development
Issue:
Volume 12:Issue 4(2023)
Page Start:
363
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single‐Dose and Multiple‐Ascending‐Dose Phase 1 Studies in Healthy Adults. Issue 2 (28th May 2020)

Authors:
Landry, Ishani; Nakai, Kenya; Ferry, Jim; Aluri, Jagadeesh; Hall, Nancy; Lalovic, Bojan; Moline, Margaret L.
Journal:
Clinical pharmacology in drug development
Issue:
Volume 10:Issue 2(2021)
Page Start:
153
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T‐cell lymphoma. Issue 6 (3rd May 2021)

Authors:
Kawai, Hidetsugu; Ando, Kiyoshi; Maruyama, Dai; Yamamoto, Kazuhito; Kiyohara, Eiji; Terui, Yasuhito; Fukuhara, Noriko; Miyagaki, Tomomitsu; Tokura, Yoshiki; Sakata‐Yanagimoto, Mamiko; Igarashi, Tadahiko; Kuroda, Junya; Fujita, Jiro; Uchida, Toshiki; Ishikawa, Takayuki; Yonekura, Kentaro; Kato, Ko...
Journal:
Cancer science
Issue:
Volume 112:Issue 6(2021)
Page Start:
2426
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗